Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy treatment regimen ...

Non-Hodgkin lymphoma is the 11th most common cause of cancer death in the UK, accounting for 3% of all cancer deaths (2017-2019).[1-4] In females in the UK, non-Hodgkin lymphoma is the 11th most ...

When your doctor talks to you about your B-cell lymphoma, they'll tell you what type you have. It's an important piece of info to get, because each type of this cancer acts differently and has its ...

Eye lymphoma, also called ocular lymphoma, is a type of eye cancer. It is the most common type of malignant eye tumor. The condition may cause eye redness or decreased vision, and it can advance to ...

The survival rate of non-Hodgkin’s lymphoma is generally lower than that of Hodgkin’s lymphoma, but it’s still often curable. Lymphoma is a group of cancers that start in the lymphatic system.

Evidence that smoking causes non-Hodgkin’s lymphoma is mixed. However, smoking might create molecules that could prevent the destruction of cancerous cells. In general, smoking increases the ...

Lymphoma is a type of cancer that begins in immune system cells, called lymphocytes. It generally presents as a solid tumor of lymphoid cells and can develop in the lymph nodes, spleen, bone ...

The specific treatment course and prognosis for T-cell lymphoma depends on the subtype — of which there are many — and how advanced the cancer is. Hodgkin lymphoma involves a type of cancer ...

There are two forms: Partial remission. Your B-cell lymphoma has gotten smaller, but it's still there. Usually the cancer has shrunk by half or more. Complete remission. Your doctor can't find any ...

The FDA has accepted the biologics licensing application (BLA) resubmission for odronextamab, a potential treatment for relapsed/refractory follicular lymphoma and diffuse large B-cell lymphoma. The ...